Innovative Partnership to Propel Development of Rare Disease Gene Therapies The ASGCT and Orphan Therapeutics Accelerator unite to enhance the commercialization of gene therapies for rare diseases, utilizing AI advancements.

Innovative Partnership to Propel Development of Rare Disease Gene Therapies #United_States #gene_therapy #Milwaukee #ASGCT #Orphan_Therapeutics

Leading Non-Profits Forge Agreement for Gene Therapy Access to Combat Ultra-Rare Diseases Orphan Therapeutics Accelerator and Fondazione Telethon unite to enhance patient access to innovative gene therapies for ultra-rare diseases, revolutionizing treatment models in the U.S.

Leading Non-Profits Forge Agreement for Gene Therapy Access to Combat Ultra-Rare Diseases #United_States #Cambridge #Fondazione_Telethon #Wiskott-Aldrich_Syndrome #Orphan_Therapeutics